To establish the current standard for open radical cystectomy (ORC) in England, as data entry by surgeons performing RC to the British Association of Urological Surgeons (BAUS) database was mandated in 2013 and combining this with Hospital Episodes Statistics (HES) data has allowed comprehensive outcome analysis for the first time.
Objective
To establish the current standard for open radical cystectomy (ORC) in England, as data entry by surgeons performing RC to the British Association of Urological Surgeons (BAUS) database was mandated in 2013 and combining this with Hospital Episodes Statistics (HES) data has allowed comprehensive outcome analysis for the first time.
Patients and Methods
All patients were included in this analysis if they were uploaded to the BAUS data registry and reported to have been performed in the 2 years between 1 January 2014 and 31 December 2015 in England (from mandate onwards) and had been documented as being performed in an open fashion (not laparoscopic, robot assisted or the technique field left blank). The HES data were accessed via the HES website. Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures version 4 (OPCS-4) Code M34 was searched during the same 2-year time frame (not including M34.4 for simple cystectomy or with additional minimal access codes Y75.1-9 documenting a laparoscopic or robotic approach was used) to assess data capture.
Results
A total of 2 537 ORCs were recorded in the BAUS registry and 3 043 in the HES data. This indicates a capture rate of 83.4% of all cases. The median operative time was 5 h, harvesting a median of 11-20 lymph nodes, with a median blood loss of 500-1 000 mL, and a transfusion rate of 21.8%. The median length of stay was 11 days, with a 30-day mortality rate of 1.58%.
Introduction
Radical cystectomy (RC) with pelvic lymph node dissection is the standard surgical treatment for the management of muscle-invasive bladder cancer (MIBC) and the highest risk non-muscle-invasive bladder cancer (NMIBC) [1] . In 2002, it was recognised that the UK management of MIBC was associated with variable outcomes across a large number of hospitals [2] . The Improving Outcomes Guidance (IOG) recommended the grouping of hospitals into networks with one 'cancer' centre carrying out the pelvic oncological procedures to enable >50 resections per year be carried out with the aim of improving outcomes and driving minimisation of morbidity and mortality. This appears to have contributed to improved 30-and 90-day mortality rates, from 2.2% to 1.3% and 5.8% to 2.6%, respectively, between 2003 and 2013 when Hospital Episode Statistics (HES) data were analysed [3] . The reasons for these improvements are multiple -for example the use of enhanced recovery, increased consultant input into surgery, and more recently minimally invasive surgery. To continue to improve we need to know the current state of cystectomy care in the UK, so any future technologies can be compared to this 'gold standard'.
The publication of consultant level mortality and quality outcomes was an initiative by the Secretary of State for Health, managed by Healthcare Quality Improvement Partnership (HQIP), an independent organisation led by the Academy of Medical Royal Colleges, The Royal College of Nursing and National Voices, established in April 2008 to promote quality in healthcare. Its premise was that the publication of such data would allow greater scrutiny and transparency, thereby increasing patient choice and driving up the quality of care. Ultimately it required NHS England to publish surgeon-level quality measures in Urology in 2013. Nephrectomy was chosen by the BAUS as it was performed by~40% of all urologists on a regular basis. As of 2016 further procedures have been added including RC and have recently been published for public consumption through the BAUS website. Data are entered by the surgeon carrying out the procedure or one of their designated departmental colleagues on their behalf through the BAUS website (www.ba us.org.uk).
Radical cystectomy has been audited for >10 years by the BAUS; however, data entry was optional and as such the number of RCs captured was low (37.1%) [4] , therefore it was not clear if the cases reviewed were representative of current UK practice. However, with the input of cases into the BAUS database being mandated from 2013 onwards, this has finally given us the ability to assess the current standard of care in the UK for RC, to which all new techniques and modifications can be compared. This is the first publication using both HES data and the BAUS cystectomy registry to define what the current standard of open RC (ORC) is in England.
The BAUS cystectomy project, being an audit does not require ethical approval as per UK National Research Ethics Service guidelines and patient identifiable data are encrypted. The BAUS collects data from surgeons in Wales, Scotland and Northern Ireland in addition to England but they have been excluded from the analysis as HES data only covers NHS-funded care in England/for English patients.
Patients and Methods
All patients were included in this analysis if they were uploaded to the BAUS data registry and reported to have been performed in the 2 years between 1 January 2014 and 31 December 2015 in England (from mandation onwards) and had been documented as being performed in an open fashion (not laparoscopic, robot assisted or the technique field left blank). The HES data were accessed via the HES website. Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures version 4 (OPCS-4) Code M34 was searched during the same 2-year time frame (not including M34.4 for simple cystectomy or with additional minimal access codes Y75.1-9 documenting a laparoscopic or robotic approach was used) to assess data capture. The registry has been analysed after the mandated deadline of 19 August 2016 to have the maximum included data. Data analysis was performed with Tableau (Tableau Software, Seattle, USA).
Results
A total of 2 537 ORCs were recorded as occurring in the 2-year period in England and were registered on the BAUS registry (Appendix S1 lists all contributors). HES data showed that during the same time frame 3 043 ORCs occurred, thus a national audit capture rate of 83.4% was obtained.
Preoperative Demographics
In all, 1 867 (73.6%) ORCs were performed on male patients and 655 (25.8%) on females. In 31 cases (0.59%) the gender was not recorded. The median age was 69 years. A total of 1 164 (45.9%) ORCs were carried out for muscle-invasive TCC. The other indications for ORC can be seen in Table 1 .
On preoperative cross-sectional imaging, 301 (11.9%) were documented as T0, carcinoma in situ (CIS) or Ta, 553 (21.8%) as T1, 872 (34.4%) as T2, 404 (17.1%) as T3, 171 (6.7%) as T4, and 236 (9.3%) were not recorded. Also, on preoperative imaging, 351 (13.8%) and 140 (5.5%) patients had unilateral and bilateral hydronephrosis, respectively, with Table 2 .
In all, 457 (18.0%) patients underwent cardio-pulmonary exercise testing before ORC and 554 patients had had neoadjuvant chemotherapy. As this is only indicated in MIBC, this gives us a neoadjuvant chemotherapy rate of 47.6%.
Case Volume
Over the 2-year period, the median (range) number of ORCs performed per consultant was 13 (1-158). The median (range) number of ORCs carried out per centre was 23 (1-187) (Fig. 1) .
Intraoperative Data
The operations took 3-5 h to perform in 1 209 (47.7%) patients, took <3 h in 261 (10.3%), took >5 h in 847 (33.4%), and the time taken was not recorded in 220 (8.7%).
Operations were carried out as joint operation procedures in 535 (21.9%) patients, 452 (17.8%) were designated as training procedures, with 92 (3.6%) carried out with the registrar as the primary surgeon.
Ileal conduits were the most common urinary diversion type, with 2 191 (86.4%) being diverted in this fashion. Orthotopic neobladders were created in 135 (5.3%) patients and 48 (1.9%) had continent cutaneous pouches formed. Four patients (0.2%) had a rectal diversion and 159 (6.3%) had another form of diversion or the field was left blank.
Intraoperative blood loss was subdivided by volume and is shown in Table 3 . Transfusion occurred in 553 (21.8%) cases and is divided into 'nil', 'minor (<2 units)', 'moderate (3-6 units)' or 'major (>6 units)' and are shown in Table 3 .
Lymph node dissection was documented as having been carried out in 1 865 (73.5%) patients. In these patients, the level of dissection was carried to a level of 1 (obturator fossa to common iliac bifurcation), 2 (up to aortic bifurcation) and 3 (up to level of inferior mesenteric artery) in 365 (19.6%), 959 (51.4%) and 296 (15.9%) respectively; and in 245 (13.1%) the level was not recorded. Yields of nodes were divided into groups of five (Table 3) , and in 1 148 cases (61.6%) ≥11 nodes were excised.
Pathological Outcomes
The known positive surgical margin rate was 7.8% (198 patients), with a negative margin rate of 70.4% (1 785 patients) and the filed was not completed in 21.8% (554 patients).
The histopathological outcomes are presented in Fig. 2 .
Mortality and Complications
The 30-day mortality rate was recorded as Postoperative complications were documented using the Clavien-Dindo grading system and for the 710 patients who had a complication, 223 had a Clavien-Dindo grade ≥III (the breakdown of grades can be seen in Table 3 ).
The median (range) length of stay was 11 (1-257) days and consistent with data from HES [3] .
Current Standard of ORC
On analysing the present data and looking at the median figures in each metric, we can therefore deduce the current standard for ORC in England (Table 4) .
Discussion
Surgery always has and always will be evolving, with the aim of improving patient outcomes. To continue improving, we need to know the current state of cystectomy care in the UK, so that future technologies or modifications can be compared. The BAUS cystectomy registry is a unique project worldwide, with no other country mandating its surgeons to enter their data at a national level, with other national databases utilised for other purposes, e.g. billing, rather than improving outcomes. The mandatory entry of all cystectomies from 2014 onwards into the BAUS registry has given a unique opportunity to assess the current practise of cystectomy in England, and we presume that similar findings are found in Wales, Scotland and Northern Ireland. However, it must be remembered that the data are entered by the surgeon (or a member of their team), which is different to other national systems (such as Surveillance, Epidemiology and End Results In the present analysis, we captured 83.4% of all ORCs that took place over 2 years in England. Data for the remaining cystectomies may have been entered but because the technique was left blank on the dataset these cases were not included for this analysis of ORCs only.
Of the data entered 100% recorded 30-day mortality rates at 1.58%. The HES figure was 1.83%. This small discrepancy may relate to the non-captured data or reflect that the HES data includes all procedure types (open, robotic, and laparoscopic). These figures compare favourably when assessed against other recently published data. Most recently, Schiffman et al. [5] reported that the 30-day mortality rate in patients aged >65 years in the USA was 5.2%. This is substantially higher than previously reported in other USA large series' in centres of excellence.
The median number of ORCs carried out by surgeon was 13 over the 2-year period and 23 per centre. The IOG was published in 2002 with key recommendations that RC should only be carried out by surgeons who are doing >5 RCs/year and in centres where >50 pelvic resections (bladder and prostates) are being carried out. These data do appear to show a continuing trend to greater centralisation, but perhaps not at the rate previously anticipated. As this audit continues it will be possible to establish whether low-volume surgeons cease to carry out the procedures and sites performing fewer cases refer their cases to an adjacent centre. This finding has been seen since the publication of the BAUS nephrectomy audit 2 years ago. The most recent data shows the number of 
Median = 23
Total by Centre Ileal conduit diversion was by far the commonest urinary diversion, and far higher than large single unit series' published [6, 7] . The choice of urinary diversion is multifactorial, and goes beyond the remit of this paper. The rate of neobladder formation is~30% in Germany as opposed to 5.3% in the present study [7] . However, when compared to another large national series the rate of ileal conduit formation here (86.4%) is not too dissimilar to the USA national rate of 91.0% [8] , thus showing we are offering a similar service to that of other comparable healthcare systems.
Cresswell et al. [4] showed in their original analysis of the BAUS cystectomy registry that the number of lymph nodes harvested at time of cystectomy was increasing over the last 10 years. As there is now a suggestion of improving overall survival if a harvest of ≥10 lymph nodes are carried out [9] a national level of 61.6% achieving this standard is encouraging. It was also found out that over time transfusion rates were decreasing. Our present findings show that the transfusion rates have continued to improve, with 64.5% of ORCs not requiring transfusion. However, we found that 50% of patients are still losing >500 mL blood, thus the low transfusion rates could be due to reasons such as preoperative iron infusions, intraoperative cell-saver salvage, and an acceptance of lower postoperative haemoglobin than previously accepted. Analyses of these data show that an ORC performed in England takes >3 h, with <10% of cases being <3 h. Also, we found that one in five cases was performed by two consultant surgeons.
The present study is limited by the fact that 16.6% of ORCs were not included in the analysis, which could change the benchmark. Even assuming that the 506 unrecorded ORCs had the worst metrics, we would expect the median to still fit within the same brackets for operative time, blood loss, and diversion type.
As with any self-completing audit, there is the suggestion of under reporting of complications, especially with regards to 90-day mortality, and is a weakness of the present study. Interestingly, we did find that the data completion rate was lower in the ORC cohort of the BAUS audit than in the minimally invasive arm, which may reflect the current enthusiasm for surgeons/units to demonstrate the benefits of using newer techniques.
Conclusions
This is the largest, contemporary cohort of ORCs in England, with >80% of all performed operations captured. We now have a far clearer understanding of current ORC practice and outcomes, together with a standard by which future techniques and modifications can be compared. Data capture continues to improve, and it will be interesting to analyse future recorded outcomes against these data.
